ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

Harkin, Hatfield Introduce Medical Research Trust Fund

March 4, 1994

NCI Budget Chief John Hartinger Retires.

August 4, 2006

American Cancer Society Awards $51.4 million in research grants

April 15, 2011

In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles

October 16, 1998